Clinical Trial Update: Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus [Phase 3]

View source ↗

Summary

A Phase 3 trial compares a new formulation of insulin glargine with Lantus in patients with Type 1 diabetes; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (new formulation) (insulin glargine)
• Lantus (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Type 1 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2015-04-23